No Data
No Data
Express News | Mesa Laboratories-Do Not Expect Material Changes, IF Any, to Results Reported in Co's Earnings Release Dated June 5, 2024 Due to Form 10-K Delay
Express News | Mesa Laboratories Inc - Files for Non- Timely 10-K With the U.S. SEC
Revenues Tell The Story For Mesa Laboratories, Inc. (NASDAQ:MLAB)
With a median price-to-sales (or "P/S") ratio of close to 3.2x in the Life Sciences industry in the United States, you could be forgiven for feeling indifferent about Mesa Laboratories, Inc.'s (NASDA
Evercore Maintains Mesa Laboratories(MLAB.US) With Buy Rating, Cuts Target Price to $120
Evercore analyst Vijay Kumar maintains $Mesa Laboratories(MLAB.US)$ with a buy rating, and adjusts the target price from $124 to $120.According to TipRanks data, the analyst has a success rate of 50.5
Express News | Mesa Laboratories Inc : Evercore ISI Cuts Target Price to $120 From $130
Mesa Laboratories Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Sales Results.
Mesa Laboratories Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Sales Results.
No Data